Search research articles
Contact Us
Filters
Showing results (261-270 of 320) with videos related to
Page
of 32
Sort By:
Therapeutic Advances in Gastroenterology
|
August 28, 2025
Real-world Effectiveness of Tofacitinib on Ulcerative Colitis-Associated Spondyloarthropathy: a multicenter prospective study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)
Fabio Salvatore Macaluso, Mauro Grova, Fabrizio Bossa, et al.
Inflammatory Bowel Diseases
|
November 22, 2025
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age
Adam S Faye, David T Rubin, Corey A Siegel, et al.
The New England Journal of Medicine
|
March 19, 2015
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease
Giovanni Monteleone, Markus F Neurath, Sandro Ardizzone, et al.
Journal of Crohn'S & Colitis
|
December 9, 2023
Epigenetic and Metabolic Reprogramming of Fibroblasts in Crohn's Disease Strictures Reveals Histone Deacetylases as Therapeutic Targets
Amy Lewis, David T Humphreys, Belen Pan-Castillo, et al.
Journal of Crohn'S & Colitis
|
December 23, 2025
Learning Curve in Intestinal Ultrasound: Advancing from Basic Skills to Advanced Competencies-Insights from the IUS IG-IBD Master Program
Cristina Bezzio, Luisa Bertin, Simone Saibeni, et al.
Alimentary Pharmacology & Therapeutics
|
October 25, 2021
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study
Cristina Bezzio, Alessandro Armuzzi, Federica Furfaro, et al.
Alimentary Pharmacology & Therapeutics
|
July 25, 2022
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study
Daniela Pugliese, Giuseppe Privitera, Federica Crispino, et al.
Autoimmunity Reviews
|
March 23, 2024
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
Fabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 15, 2022
Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition
Giulia Rizzo, Federica Rubbino, Sudharshan Elangovan, et al.
BMC Surgery
|
February 26, 2024
Optimising surgical anastomosis in ileocolic resection for Crohn's disease with respect to recurrence and functionality: two international parallel randomized controlled trials comparing handsewn (END-to-end or Kono-S) to stapled anastomosis (HAND2END and the End2End STUDIES)
Anouck E G Haanappel, Vittoria Bellato, Christianne J Buskens, et al.
Page
of 32
Search research articles
Search
Showing results (261-270 of 320) with videos related to
Sort By:
Page
of 32
Therapeutic Advances in Gastroenterology
|
August 28, 2025
Real-world Effectiveness of Tofacitinib on Ulcerative Colitis-Associated Spondyloarthropathy: a multicenter prospective study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD)
Fabio Salvatore Macaluso, Mauro Grova, Fabrizio Bossa, et al.
Inflammatory Bowel Diseases
|
November 22, 2025
Safety and Efficacy of Ozanimod in Patients With Moderately to Severely Active Ulcerative Colitis Stratified by Age
Adam S Faye, David T Rubin, Corey A Siegel, et al.
The New England Journal of Medicine
|
March 19, 2015
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease
Giovanni Monteleone, Markus F Neurath, Sandro Ardizzone, et al.
Journal of Crohn'S & Colitis
|
December 9, 2023
Epigenetic and Metabolic Reprogramming of Fibroblasts in Crohn's Disease Strictures Reveals Histone Deacetylases as Therapeutic Targets
Amy Lewis, David T Humphreys, Belen Pan-Castillo, et al.
Journal of Crohn'S & Colitis
|
December 23, 2025
Learning Curve in Intestinal Ultrasound: Advancing from Basic Skills to Advanced Competencies-Insights from the IUS IG-IBD Master Program
Cristina Bezzio, Luisa Bertin, Simone Saibeni, et al.
Alimentary Pharmacology & Therapeutics
|
October 25, 2021
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study
Cristina Bezzio, Alessandro Armuzzi, Federica Furfaro, et al.
Alimentary Pharmacology & Therapeutics
|
July 25, 2022
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE study
Daniela Pugliese, Giuseppe Privitera, Federica Crispino, et al.
Autoimmunity Reviews
|
March 23, 2024
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
Fabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, et al.
Cellular and Molecular Gastroenterology and Hepatology
|
December 15, 2022
Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition
Giulia Rizzo, Federica Rubbino, Sudharshan Elangovan, et al.
BMC Surgery
|
February 26, 2024
Optimising surgical anastomosis in ileocolic resection for Crohn's disease with respect to recurrence and functionality: two international parallel randomized controlled trials comparing handsewn (END-to-end or Kono-S) to stapled anastomosis (HAND2END and the End2End STUDIES)
Anouck E G Haanappel, Vittoria Bellato, Christianne J Buskens, et al.
Page
of 32